Tech Company Financing Transactions
Commit Biologics Funding Round
Commit Biologics secured a $17 million Seed funding round on 5/9/2024. Investors included Bioqube Ventures and Novo Holdings.
Transaction Overview
Company Name
Announced On
5/9/2024
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate development of its Bispecific Complement Engaging (BiCE�) platform.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Universitetsbyen 83
Aarhus C, 8000
Denmark
Aarhus C, 8000
Denmark
Phone
Website
Email Address
Overview
Founded in 2021, Commit Biologics is a biotech spin-out from Aarhus University in Denmark -- an academic institution with a global reputation in complement system biology from more than three decades of complement research. The Commit team combines expertise in antibody development and complement research to develop a new type of therapeutics to treat cancer and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Krishna Polu
Chief Operating Officer
Dennis Pedersen
Chief Scientific Officer
Nick Laursen
Chief Technical Officer
Mikael Winkler
Co-Founder
Heidi Olesen
VP - Bus. Development
Pascal Merchiers
Browse more venture capital transactions:
Prev: 5/9/2024: Li Industries venture capital transaction
Next: 5/9/2024: Arcium venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs